Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |